CMS Ventures — Full Portfolio
2 tracked investments · listed companies and verified rows first
CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision.
BiotechHealthtechMedical Devices
Dr Matthew Cummings(Co-Founder, CC Bio)Dr David Corcoran(Co-Founder, CC Bio)
Co-investorsDeep Science Ventures
Qureight is a UK AI-powered imaging CRO providing enterprise-grade imaging and precision endpoints for lung and heart disease trials.
Muhunthan Thillai(Founder)in
Co-investorsAscensionCambridge Angels groupGuinness VenturesMolten VenturesPlayfair CapitalXTX Markets
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





